Novavax (NVAX) ended the recent trading session at $8.46, demonstrating a -1.51% change from the preceding day's closing price. This change lagged the S&P 500's 0.53% loss on the day. Meanwhile, the ...

Himanshu Shah, managing partner and chief investment officer at Shah Capital, slammed management, and said the company should ...

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at ...

If you have been tracking Novavax, you know it is the kind of stock that makes you wonder whether to hold on, cut losses, or set up for a comeback. Over the last month, the stock has climbed a sturdy ...

Novavax (NVAX) has caught the attention of investors this month, as its stock climbed over 26% in the past 30 days. The company’s performance draws curiosity about what might be fueling the move, ...

Novavax (NVAX) stock is in focus as the company assign its Gaithersburg facility to AstraZeneca (AZN) in a deal worth nearly ...

This was the stock's second consecutive day of losses.

Investing.com -- Novavax Inc (NASDAQ:NVAX) stock gained 2% Tuesday after Shah Capital, the company’s second-largest shareholder, sent a letter to the board urging an immediate strategic review for a ...

Stream Connecticut News for free, 24/7, wherever you are. Novavax could pay up to $475 million to the organization, but the total amount may be less if Gavi decides to order more shots from the ...

Novavax presents a confusing picture for market participants, with analyst estimates painting two starkly different scenarios. While the biotechnology firm's full-year projections suggest ...

Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by Bay Street pros, advisors and Canadians who invest on their own, they help ...

This was the stock's second consecutive day of losses.